Clinical Trials
358 trialsLow-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC
Sichuan University
Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer
National Institutes of Health Clinical Center (CC)
Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
Fudan University
Perioperative Immunotherapy for NSCLC (ECTOP-1030)
Fudan University
Lung Cancer Screening CT for Firefighters
University of California, San Francisco
Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
INDIGO
Gustave Roussy, Cancer Campus, Grand Paris
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
National Institutes of Health Clinical Center (CC)
CheckCell-2
Intima Bioscience, Inc.
ARTIA-Lung
Varian, a Siemens Healthineers Company
EPIC
Therakos LLC
Neo-Kan
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
BIB 01
Institut Bergonié
EMPIRE
Institut Bergonié
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
Sutro Biopharma, Inc.
TUXEDO-5
MedSIR
CH:II
Lady Davis Institute
Vaccination of Advanced-Stage Lung Cancer Patients
University of Arkansas
Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
National Institutes of Health Clinical Center (CC)
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
City of Hope Medical Center
Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
M.D. Anderson Cancer Center
Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma
Wake Forest University Health Sciences
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Rutgers, The State University of New Jersey
Phase Ib Study of FURMONERTINIB in Patients with NSCLC Having Exon 20 Insertion Mutation
Allist Pharmaceuticals, Inc.
ELEVATE
Prisma Health-Midlands
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
ImmunityBio, Inc.
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
ImmunityBio, Inc.
A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions
Auris Health, Inc.
A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors
Astellas Pharma Inc
Bupivacaine Liposome Serrate Anterior Plane Block vs Traditional Thoracic Paravertebral Block
Shanghai Pulmonary Hospital, Shanghai, China
Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases
University of Texas Southwestern Medical Center
POIMS
University of Kansas Medical Center
NEGOTIATE
Sun Yat-sen University
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
APPEAL
Sun Yat-sen University
AERESA
Sun Yat-sen University
NAJSCR
Sun Yat-sen University
LC_ART
Abramson Cancer Center at Penn Medicine
AMBER
ETOP IBCSG Partners Foundation
Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study
M.D. Anderson Cancer Center
BOUNCE
ETOP IBCSG Partners Foundation
An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
Roswell Park Cancer Institute
Using Circulating Tumor DNA to Personalize Duration of Consolidation Durvalumab
Indiana University
Re-Induce 2
Maastricht Radiation Oncology
HAITEN-ICI
VA Office of Research and Development
SCION
University of British Columbia
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
University of Chicago
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
SWOG Cancer Research Network
Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein
AbbVie